K
Kepal N. Patel
Researcher at New York University
Publications - 71
Citations - 2081
Kepal N. Patel is an academic researcher from New York University. The author has contributed to research in topics: Medicine & Thyroid cancer. The author has an hindex of 21, co-authored 55 publications receiving 1739 citations. Previous affiliations of Kepal N. Patel include Memorial Sloan Kettering Cancer Center & Stony Brook University Hospital.
Papers
More filters
Journal ArticleDOI
Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules
Kepal N. Patel,Trevor E. Angell,Joshua E. Babiarz,Neil M. Barth,Thomas Blevins,Quan-Yang Duh,Ronald Ghossein,R. Mack Harrell,Jing Huang,Giulia C. Kennedy,Su Yeon Kim,Richard T. Kloos,Virginia A. LiVolsi,Gregory W. Randolph,Peter M. Sadow,Michael H. Shanik,Julie Ann Sosa,S. Thomas Traweek,P. Sean Walsh,Duncan Whitney,Michael W. Yeh,Paul W. Ladenson +21 more
TL;DR: Its 36% increase in specificity compared with the gene expression classifier potentially increases the number of patients with benign nodules who can safely avoid unnecessary diagnostic surgery.
Journal ArticleDOI
Poorly differentiated and anaplastic thyroid cancer.
Kepal N. Patel,Ashok R. Shaha +1 more
TL;DR: PDTC and ATC are rare diseases that carry a poor prognosis and recognition of their different clinicopathologic features is important to the optimal management of these tumors.
Journal ArticleDOI
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making.
Robert L. Ferris,Zubair W. Baloch,Victor Bernet,Amy Y. Chen,Thomas J. Fahey,Ian Ganly,Steven P. Hodak,Electron Kebebew,Kepal N. Patel,Ashok R. Shaha,David L. Steward,Ralph P. Tufano,Sam M. Wiseman,Sally E. Carty +13 more
TL;DR: This review covers the clinical scenarios by cytologic category for which the thyroid surgeon may find molecular profiling results useful, particularly for cases with indeterminate fine-needle aspiration cytology.
Journal ArticleDOI
Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
Ian Ganly,Vladimir Makarov,Shyamprasad Vasudeva Deraje,Yiyu Dong,Ed Reznik,Venkatraman E. Seshan,Gouri Nanjangud,Stephanie Eng,Promita Bose,Fengshen Kuo,Luc G. T. Morris,Iñigo Landa,Pedro Blecua Carrillo Albornoz,Nadeem Riaz,Yuri E. Nikiforov,Kepal N. Patel,Christopher B. Umbricht,Martha A. Zeiger,Electron Kebebew,Eric J. Sherman,Ronald Ghossein,James A. Fagin,Timothy A. Chan +22 more
TL;DR: A comprehensive genomic characterization of 56 primary HCC tumors that span the spectrum of tumor behavior is described and reveals unique chromosomal landscapes that involve whole-chromosomal duplications of chromosomes 5 and 7 and widespread loss of heterozygosity arising from haploidization and copy-number-neutral uniparental disomy.
Journal ArticleDOI
Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes.
Jennifer L. Andruchow,Michael J. Veness,Gary J. Morgan,Kan Gao,Anthony Clifford,Kerwin F. Shannon,Michael Poulsen,Lizbeth Kenny,Carsten E. Palme,Patrick Gullane,Christopher G. Morris,William M. Mendenhall,Kepal N. Patel,Jatin P. Shah,Christopher J. O'Brien +14 more
TL;DR: A new staging system that may provide better discrimination between patient groups is tested for metastatic skin carcinoma in patients with cutaneous squamous cell carcinoma.